Search details
1.
Trends in treatment patterns and costs of care among patients with advanced stage cervical cancer.
Gynecol Oncol
; 164(3): 645-650, 2022 03.
Article
in English
| MEDLINE | ID: mdl-35031189
2.
Key learnings from Institute for Clinical and Economic Review's real-world evidence reassessment pilot.
Int J Technol Assess Health Care
; 38(1): e32, 2022 Mar 14.
Article
in English
| MEDLINE | ID: mdl-35357284
3.
Are Drugs Priced in Accordance With Value? A Comparison of Value-Based and Net Prices Using Institute for Clinical and Economic Review Reports.
Value Health
; 24(6): 789-794, 2021 06.
Article
in English
| MEDLINE | ID: mdl-34119076
4.
Real-world economic impact of onabotulinumtoxinA in patients with chronic migraine.
Headache
; 54(10): 1565-73, 2014.
Article
in English
| MEDLINE | ID: mdl-25298117
5.
Treatment persistence and switching in triptan users: a systematic literature review.
Headache
; 54(7): 1120-30, 2014.
Article
in English
| MEDLINE | ID: mdl-24912394
6.
Validation of the Headache Impact Test (HIT-6) in patients with chronic migraine.
Health Qual Life Outcomes
; 12: 117, 2014 Aug 01.
Article
in English
| MEDLINE | ID: mdl-25080874
7.
Systematic literature review and meta-analysis of HER2 amplification, overexpression, and positivity in colorectal cancer.
JNCI Cancer Spectr
; 8(1)2024 Jan 04.
Article
in English
| MEDLINE | ID: mdl-37815820
8.
Headache-related health resource utilisation in chronic and episodic migraine across six countries.
J Neurol Neurosurg Psychiatry
; 84(12): 1309-17, 2013 Dec.
Article
in English
| MEDLINE | ID: mdl-23813744
9.
Patterns of use and reasons for discontinuation of prophylactic medications for episodic migraine and chronic migraine: results from the second international burden of migraine study (IBMS-II).
Headache
; 53(4): 644-55, 2013 Apr.
Article
in English
| MEDLINE | ID: mdl-23458496
10.
The psychometric properties of the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQ) in chronic migraine patients.
Qual Life Res
; 22(5): 1123-33, 2013 Jun.
Article
in English
| MEDLINE | ID: mdl-22797868
11.
Total healthcare cost savings through improved bipolar I disorder identification using the Rapid Mood Screener in patients diagnosed with major depressive disorder.
Curr Med Res Opin
; 39(4): 605-611, 2023 04.
Article
in English
| MEDLINE | ID: mdl-36776128
12.
Healthcare resource utilization and costs among patients with post-stroke spasticity before and after spasticity management including onabotulinumtoxina.
J Rehabil Med
; 55: jrm11626, 2023 Oct 30.
Article
in English
| MEDLINE | ID: mdl-37902443
13.
Impact of Ruxolitinib Cream on Work Productivity and Activity Impairment and Associated Indirect Costs in Patients with Atopic Dermatitis: Pooled Results From Two Phase III Studies.
Am J Clin Dermatol
; 24(1): 109-117, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36264430
14.
Systematic Literature Review (SLR) and Network Meta-Analysis (NMA) of First-Line Therapies (1L) for Locally Advanced/Metastatic Urothelial Carcinoma (la/mUC).
Curr Oncol
; 30(4): 3637-3647, 2023 03 26.
Article
in English
| MEDLINE | ID: mdl-37185390
15.
Adherence with migraine prophylaxis in clinical practice.
Pain Pract
; 12(7): 541-9, 2012 Sep.
Article
in English
| MEDLINE | ID: mdl-22300068
16.
HER2 expression in urothelial carcinoma, a systematic literature review.
Front Oncol
; 12: 1011885, 2022.
Article
in English
| MEDLINE | ID: mdl-36338710
17.
Oncology Simulation Model: A Comprehensive and Innovative Approach to Estimate and Project Prevalence and Survival in Oncology.
Clin Epidemiol
; 14: 1375-1386, 2022.
Article
in English
| MEDLINE | ID: mdl-36404878
18.
The effectiveness and value of targeted immune modulators for moderate to severe ulcerative colitis.
J Manag Care Spec Pharm
; 27(3): 405-410, 2021 Mar.
Article
in English
| MEDLINE | ID: mdl-33645245
19.
Optimal treatment sequence for targeted immune modulators for the treatment of moderate to severe ulcerative colitis.
J Manag Care Spec Pharm
; 27(8): 1046-1055, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-34337994
20.
Cost-effectiveness of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis.
J Med Econ
; 24(1): 29-37, 2021.
Article
in English
| MEDLINE | ID: mdl-33256494